Skip to main content

Advertisement

SpringerLink
Log in

Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS)

  • Clinical Trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Whether wide excision with margins ≥1 cm is sufficient treatment for small low- or intermediate-grade ductal carcinoma in situ (DCIS) is unclear. This is an updated analysis of a phase II, single-arm, prospective trial testing this hypothesis. A total of 158 patients with low- or intermediate-grade DCIS who underwent wide excision alone (without radiation or tamoxifen) were entered onto the trial from 1995 to 2002. Entry criteria included mammographic extent ≤2.5 cm, predominantly low or intermediate nuclear grade, and excision with final microscopic margins ≥1 cm. Eight-year minimum potential follow-up was required for inclusion in the analysis; the final population comprised 143 patients. Cumulative incidence curves were generated to assess rates of local recurrence (LR) or other events. Median follow-up time was 11 years. Nineteen patients (13 %) had LR as a first event within 8 years. Thirteen LR (68 %) were DCIS only and six (32 %) were invasive. Fourteen (74 %) occurred in the original quadrant. The 10-year estimated cumulative incidence of LR was 15.6 %. The estimated annual percentage rate of LR was 1.9 % per patient-year. With longer follow-up, there remains a substantial and ongoing risk of LR in patients with favorable DCIS treated with wide excision margins without radiation. This information should be useful as patients and clinicians weigh the options of wide excision with and without radiation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Brinton LA, Sherman ME, Carreon JD et al (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100:1643–1648

    Article  PubMed  Google Scholar 

  2. Virnig BA, Tuttle TM, Shamliyan T et al (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170–178

    Article  PubMed  Google Scholar 

  3. Fisher ER, Dignam J, Tan-Chiu E et al (1999) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86:429–438

    Article  CAS  PubMed  Google Scholar 

  4. Fisher B, Land S, Mamounas E et al (2001) Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28:400–418

    Article  CAS  PubMed  Google Scholar 

  5. Wapnir IL, Dignam JJ, Fisher B et al (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478–488

    Article  PubMed  Google Scholar 

  6. Cuzick J, Sestak I, Pinder SE et al (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21–29

    Article  CAS  PubMed  Google Scholar 

  7. Bijker N, Meijnen P, Peterse JL et al (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059

    Article  PubMed  Google Scholar 

  8. Holmberg L, Garmo H, Granstrand B et al (2008) Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26:1247–1252

    Article  PubMed  Google Scholar 

  9. Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455–1461

    Article  CAS  PubMed  Google Scholar 

  10. Initial National Priorities for Comparative Effectiveness Research (2009). The National Academies Press, Washington, DC

  11. Wong JS, Kaelin CM, Troyan SL et al (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24:1031–1036

    Article  PubMed  Google Scholar 

  12. Gray RJ (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141–1154

    Article  Google Scholar 

  13. Correa C, McGale P, Taylor C et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162–177

    Article  CAS  PubMed  Google Scholar 

  14. Macdonald HR, Silverstein MJ, Lee LA et al (2006) Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast. Am J Surg 192:420–422

    Article  PubMed  Google Scholar 

  15. Hughes LL, Wang M, Page DL et al (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319–5324

    Article  PubMed  Google Scholar 

  16. Solin LJ, Gray R, Baehner FL et al (2013) A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst 105:701–710

    Article  CAS  PubMed  Google Scholar 

  17. Alvarado R, Lari SA, Roses RE et al (2012) Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol 19:3777–3784

    Article  PubMed  Google Scholar 

  18. Pinder SE, Duggan C, Ellis IO et al (2010) A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial. Br J Cancer 103:94–100

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Solin LJ, Kurtz J, Fourquet A et al (1996) Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754–763

    CAS  PubMed  Google Scholar 

  20. Lee LA, Silverstein MJ, Chung CT et al (2006) Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in situ of the breast. Am J Surg 192:416–419

    Article  PubMed  Google Scholar 

  21. Bijker N, Peterse JL, Duchateau L et al (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19:2263–2271

    CAS  PubMed  Google Scholar 

  22. Roses RE, Arun BK, Lari SA et al (2011) Ductal carcinoma-in situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol 18:2873–2878

    Article  PubMed  Google Scholar 

  23. Solin LJ, Fourquet A, Vicini FA et al (2001) Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer 91:1090–1097

    Article  CAS  PubMed  Google Scholar 

  24. Suh WW, Hillner BE, Pierce LJ et al (2005) Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 61:1054–1061

    Article  PubMed  Google Scholar 

  25. McCormick B (2012) RTOG 9804: a prospective randomized trial for “good risk” ductal carcinoma in situ (DCIS), comparing radiation (RT) to observation (OBS). ASCO Meeting Abstracts 30:1004

  26. Hiramatsu H, Bornstein BA, Recht A et al (1995) Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: possible importance of family history. Cancer J Sci Am 1:55–61

    CAS  PubMed  Google Scholar 

  27. Halasz LM, Sreedhara M, Chen YH et al (2012) Improved outcomes of breast-conserving therapy for patients with ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 82:e581–e586

    Article  PubMed  Google Scholar 

  28. Lari SA, Kuerer HM (2011) Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer 2:232–261

    Article  PubMed Central  PubMed  Google Scholar 

  29. Esserman LJ, Thompson IM, Reid B (2013) Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310:797–798

    Article  PubMed  Google Scholar 

  30. Soeteman DI, Stout NK, Ozanne EM et al (2013) Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst 105:774–781

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women’s Hospital and Harvard Medical School , Boston, MA, USA

    Julia S. Wong, Barbara J. Silver & Jay R. Harris

  2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA

    Yu-Hui Chen & Rebecca Gelman

  3. Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Michele A. Gadd & Barbara L. Smith

  4. Department of Pathology, Dana-Farber Cancer Institute/Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Susan C. Lester

  5. Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

    Stuart J. Schnitt

  6. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Dennis C. Sgroi

  7. Department of Surgery, Dana-Farber Cancer Institute/Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Susan L. Troyan

Authors
  1. Julia S. Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu-Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michele A. Gadd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebecca Gelman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Susan C. Lester
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stuart J. Schnitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Dennis C. Sgroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Barbara J. Silver
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Barbara L. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Susan L. Troyan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jay R. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julia S. Wong.

Additional information

This manuscript contains original work and was presented in part at the 53rd Annual Meeting of the American Society for Radiation Oncology, Miami, FL, USA, October 2011.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, J.S., Chen, YH., Gadd, M.A. et al. Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS). Breast Cancer Res Treat 143, 343–350 (2014). https://doi.org/10.1007/s10549-013-2813-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-013-2813-6

Keywords

Search

Navigation